Antibody-drug conjugates (ADCs) are a rapidly evolving class of anticancer therapeutics consisting of antibodies attached to potent cytotoxic drugs via chemical linkers. What're the prospects and challenges of Antibody-Drug Conjugates for cancer therapy?